Le Lézard
Classified in: Health
Subjects: CHI, CSR

Bringing Scoliosis to the Forefront


CLEVELAND, June 13, 2018 /PRNewswire/ -- Today, scoliosis often takes a backseat to other childhood health concerns.  During National Scoliosis Awareness Month in June, the goal is to bring attention to this spinal condition, which can be effectively managed if detected early.   HealthSource, America's largest group of clinics specializing in chiropractic and holistic healthcare, is leading a campaign to educate parents on ways to detect and treat scoliosis.  The campaign includes presentations at community centers, summer schools and local events.  Participating clinics are also offering free scoliosis exams.

More than 3 million new cases of scoliosis are reported in the United States every year, with the majority being idiopathic scoliosis, the most common form impacting children.  While there is no cure for scoliosis, early detection can prevent deformity resulting in back pain, unsightly posture and the body's range of motion.  Pressure on the spine from playing contact team sports, carrying heavy backpacks and frequently bending the head while using smart phones can exacerbate problems for those with scoliosis, but are not causes for the condition.  The bottom line is parents need to be aware of common signs of scoliosis, and if they have any doubts, schedule a scoliosis exam for their child.

In 2004, the US Preventative Service Task Force called for an end to scoliosis screening at public schools.  While a number of states still recommend school-based scoliosis screening, with budget constraints, many schools have dropped the exams.  Those with have a family history for scoliosis are most at risk.

Visual Signs of Scoliosis:

If your child is diagnosed with scoliosis, there is no need to panic.  "Scoliosis is a very manageable condition when diagnosed early," says Dr. Chris Tomshack, CEO and founder of HealthSource.  "It's best to identify before the child has a growth spurt.  In most cases, treatment involves scoliosis massages, stretches and exercise along with scoliosis specific adjustments.  Only 30% of those diagnosed with scoliosis need bracing, and even less ? under 10% ?  require surgery." 

About HealthSource

HealthSource, a national holistic care and chiropractic franchise, treats pain throughout the entire body, sciatica, fibromyalgia and other common concerns, and also focuses on pain prevention and nutrition. The company continually implements new treatments and medical advancements, staying on the cutting edge of medicine. HealthSource began franchising in 2006 and more than 300 domestic and international locations. For more information about HealthSource, visit www.healthsourcechiro.com.

CONTACT: Matt Siegler, Fishman Public Relations, (847) 945-1300 or [email protected]

SOURCE HealthSource


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: